Why do you think they should skip liver cancer? Looks a big market especially Asia , yes crowded space competition with other treatments but a small segment of big market is still worthwhile imo agree with you point about add on, for example combine with immunotherapy (checkpoint inhibitor) is possible I think I heard somebody mentioning this once somewhere possibly old investor call
OSL Price at posting:
4.7¢ Sentiment: None Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)